{"id":346021,"date":"2025-08-25T09:36:11","date_gmt":"2025-08-25T09:36:11","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-quest-diagnostics-incorporated\/"},"modified":"2025-08-25T09:36:11","modified_gmt":"2025-08-25T09:36:11","slug":"how-to-buy-quest-diagnostics-incorporated","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/","title":{"rendered":"Quest Diagnostics Incorporated (DGX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Quest Diagnostics Incorporated (DGX) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334054,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-346021","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Quest Diagnostics Incorporated (DGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Quest Diagnostics Incorporated (DGX) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Quest Diagnostics Incorporated (DGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Quest Diagnostics Incorporated (DGX) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Mevcut fiyat analizi, 2025-2030 tahminleri ve sa\u011fl\u0131k sekt\u00f6r\u00fc maruziyeti i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ile Quest Diagnostics (DGX) hissesine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Mevcut fiyat analizi, 2025-2030 tahminleri ve sa\u011fl\u0131k sekt\u00f6r\u00fc maruziyeti i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcreci ile Quest Diagnostics (DGX) hissesine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin."},"intro":"Portf\u00f6y\u00fcn\u00fcze bir sa\u011fl\u0131k devi eklemeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? Quest Diagnostics (DGX), dalgal\u0131 t\u0131bbi sekt\u00f6rde istikrar\u0131 temsil ederken, tan\u0131sal yenilik yoluyla b\u00fcy\u00fcme potansiyeli sunuyor. Amerika'n\u0131n en b\u00fcy\u00fck klinik test sa\u011flay\u0131c\u0131lar\u0131ndan biri olarak, bu \u015firket her g\u00fcn milyonlarca hayat\u0131 etkiliyor. Mevcut hisse performans\u0131ndan 2025 i\u00e7in ak\u0131ll\u0131 giri\u015f stratejilerine kadar her \u015feyi ke\u015ffedece\u011fiz.","intro_source":{"label":"Intro","type":"text","formatted_value":"Portf\u00f6y\u00fcn\u00fcze bir sa\u011fl\u0131k devi eklemeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? Quest Diagnostics (DGX), dalgal\u0131 t\u0131bbi sekt\u00f6rde istikrar\u0131 temsil ederken, tan\u0131sal yenilik yoluyla b\u00fcy\u00fcme potansiyeli sunuyor. Amerika'n\u0131n en b\u00fcy\u00fck klinik test sa\u011flay\u0131c\u0131lar\u0131ndan biri olarak, bu \u015firket her g\u00fcn milyonlarca hayat\u0131 etkiliyor. Mevcut hisse performans\u0131ndan 2025 i\u00e7in ak\u0131ll\u0131 giri\u015f stratejilerine kadar her \u015feyi ke\u015ffedece\u011fiz."},"body_html":"<h2>\ud83d\udcc8 Quest Diagnostics Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2> <p>25 A\u011fustos 2025 itibar\u0131yla, Quest Diagnostics Incorporated (DGX) NYSE'de <strong>180,23 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>28 Ekim 2025<\/strong> kesinlikle kritik\u2014bu tarihte Quest 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak. Tarihsel olarak, bu \u00e7eyrek d\u00f6nem duyurular\u0131 \u00f6nemli fiyat hareketleri yarat\u0131yor.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 DGX Hissesini Nas\u0131l Hareket Ettirir<\/h3> <p>Son tarihe bak\u0131ld\u0131\u011f\u0131nda, Quest'in kazan\u00e7 g\u00fcnleri \u00f6zellikle volatil olmu\u015ftur:<\/p> <ul> <li><strong>22 Temmuz 2025<\/strong>: 2. \u00e7eyrek kazan\u00e7lar\u0131 beklentileri $2,62 EPS ile a\u015ft\u0131 (0,05 $ fazla) ve 2,76 milyar $ gelir (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NYSE\/DGX\/earnings\/\">MarketBeat<\/a>). Hisse senedi sonraki hafta %3,2 y\u00fckseldi<\/li> <li><strong>Nisan 2025<\/strong>: 1. \u00e7eyrek sonu\u00e7lar\u0131 %12 gelir art\u0131\u015f\u0131 g\u00f6sterdi, \u00fc\u00e7 i\u015flem g\u00fcn\u00fcnde %5,1 art\u0131\u015f tetikledi<\/li> <li><strong>Ocak 2025<\/strong>: Y\u0131ll\u0131k rehberlik art\u0131\u015f\u0131 \u015eubat boyunca %7,8'lik s\u00fcrekli bir ralliyi tetikledi<\/li> <\/ul> <p>Desen a\u00e7\u0131k: pozitif s\u00fcrprizler an\u0131nda momentum yarat\u0131rken, k\u00fc\u00e7\u00fck ka\u00e7\u0131rmalar bile ge\u00e7ici d\u00fc\u015f\u00fc\u015flere neden olabilir; ancak Quest'in savunmac\u0131 i\u015f modeli sayesinde bu d\u00fc\u015f\u00fc\u015fler genellikle haftalar i\u00e7inde toparlan\u0131r.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Son Konsolidasyonla \u0130stikrarl\u0131 T\u0131rman\u0131\u015f<\/h2> <p>Quest Diagnostics, piyasa dalgalanmalar\u0131 aras\u0131nda ola\u011fan\u00fcst\u00fc bir istikrar g\u00f6sterdi:<\/p> <p><strong>\u015eubat 2025<\/strong>: 162,50 $ (tatil sonras\u0131 sa\u011fl\u0131k sekt\u00f6r\u00fc rotasyonu)<br\/> <strong>Mart 2025<\/strong>: 171,80 $ (LifeLabs Kanada anla\u015fmas\u0131 haberleriyle hareketlilik)<br\/> <strong>May\u0131s 2025<\/strong>: 178,40 $ (g\u00fc\u00e7l\u00fc 1. \u00e7eyrek kazan\u00e7 momentumu)<br\/> <strong>Temmuz 2025<\/strong>: 183,50 $ (2. \u00e7eyrek kazan\u00e7lar\u0131 ve rehberlik art\u0131\u015f\u0131)<br\/> <strong>A\u011fustos 2025<\/strong>: 180,23 $ (52 haftal\u0131k zirvelere yak\u0131n mevcut konsolidasyon)<\/p> <p>Hisse senedi bu alt\u0131 ayl\u0131k d\u00f6nemde yakla\u015f\u0131k <strong>%11,2<\/strong> de\u011fer kazand\u0131, bir\u00e7ok sa\u011fl\u0131k sekt\u00f6r\u00fc rakibini geride b\u0131rak\u0131rken karakteristik d\u00fc\u015f\u00fck volatilitesini (beta 0,46) korudu. Bu istikrarl\u0131 de\u011fer art\u0131\u015f\u0131, hem operasyonel m\u00fckemmeliyeti hem de ekonomik belirsizlik d\u00f6nemlerinde tan\u0131sal hizmetlerin savunmac\u0131 do\u011fas\u0131n\u0131 yans\u0131t\u0131yor.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p>Kapsaml\u0131 analist projeksiyonlar\u0131 ve sekt\u00f6r trendlerine dayanarak:<\/p> <p><strong>2025 Y\u0131l Sonu<\/strong>: 188-195 $ (3. ve 4. \u00e7eyrek kazan\u00e7lar\u0131 sonras\u0131 \u0131l\u0131ml\u0131 b\u00fcy\u00fcme) \u2192 <strong>AL<\/strong><br\/> <strong>2026 Hedefi<\/strong>: 204-215 $ (geni\u015fleyen tan\u0131sal hizmetlerden %8-12 b\u00fcy\u00fcme)<br\/> <strong>2028 Projeksiyonu<\/strong>: 230-245 $ (Yapay zeka entegrasyonundan bile\u015fik y\u0131ll\u0131k b\u00fcy\u00fcme)<br\/> <strong>2030 Vizyonu<\/strong>: 260-280 $ (ya\u015flanan n\u00fcfus talebi ve ki\u015fiselle\u015ftirilmi\u015f t\u0131p benimsemesi)<\/p> <p>Ortak g\u00f6r\u00fc\u015f, Quest'in pazar liderli\u011fi, tekrarlayan gelir modeli ve artan tan\u0131sal test ihtiyac\u0131 nedeniyle iyimserdir.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler:<\/h3> <ul> <li><strong>Artan bor\u00e7 y\u00fck\u00fc<\/strong> D\/E oran\u0131 0,71 ile finansal esnekli\u011fi k\u0131s\u0131tlayabilir<\/li> <li><strong>Sa\u011fl\u0131k geri \u00f6demelerinde d\u00fczenleyici de\u011fi\u015fiklikler<\/strong> marjlar \u00fczerinde bask\u0131 olu\u015fturabilir<\/li> <li><strong>Teknik g\u00f6stergeler<\/strong> son zay\u0131fl\u0131kla 4,87\/10 puan g\u00f6steriyor<\/li> <li><strong>Makroekonomik duyarl\u0131l\u0131k<\/strong> t\u00fcketici sa\u011fl\u0131k harcamalar\u0131 d\u00fc\u015ferse etkilenebilir<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar:<\/h3> <ul> <li><strong>2. \u00e7eyrek kazan\u00e7lar\u0131 a\u015fmas\u0131<\/strong> %15,2 gelir art\u0131\u015f\u0131 ve tam y\u0131l rehberli\u011fi y\u00fckseltti<\/li> <li><strong>Kurumsal hesap geni\u015flemesi<\/strong> tutarl\u0131 gelir ak\u0131\u015flar\u0131n\u0131 destekliyor<\/li> <li><strong>Otomasyon kazan\u0131mlar\u0131<\/strong> operasyonel verimlilik ve karl\u0131l\u0131\u011f\u0131 art\u0131r\u0131yor<\/li> <li><strong>\u00c7eyreklik temett\u00fc art\u0131\u015f\u0131<\/strong> 0,80 $ (y\u00fczde 6,7 art\u0131\u015f) g\u00fcven sinyali<\/li> <li><strong>Ekonomik belirsizlikte sa\u011fl\u0131k sekt\u00f6r\u00fc istikrar\u0131<\/strong><\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>Dolar-maliyet ortalamas\u0131<\/strong> - Zamanlama hatalar\u0131n\u0131 \u00f6nlemek i\u00e7in ayl\u0131k sabit tutarlarda yat\u0131r\u0131m yap\u0131n<\/li> <li><strong>Kazan\u00e7 uyar\u0131lar\u0131 ayarlay\u0131n<\/strong> - Potansiyel giri\u015f f\u0131rsatlar\u0131 i\u00e7in 28 Ekim'i takip edin<\/li> <li><strong>Ak\u0131ll\u0131ca tahsis yap\u0131n<\/strong> - DGX'i portf\u00f6y\u00fcn\u00fcz\u00fcn %5-10'u aras\u0131nda tutarak sekt\u00f6r \u00e7e\u015fitlendirmesi sa\u011flay\u0131n<\/li> <li><strong>Temett\u00fcleri yeniden yat\u0131r\u0131n<\/strong> - %1,78 getiri bile\u015fik b\u00fcy\u00fcme i\u00e7in kullan\u0131n<\/li> <\/ol> <p>Esprili bir bak\u0131\u015f: \"DGX ticareti, laboratuvar sonu\u00e7lar\u0131n\u0131 almak gibidir - bazen iyi haberi almak i\u00e7in i\u015flem s\u00fcresini beklemeniz gerekir. Sab\u0131r genellikle \u00f6d\u00fcllendirilir!\"<\/p> <h2>\u2705 Quest Diagnostics Incorporated (DGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Yat\u0131r\u0131m platformu se\u00e7in<\/td><td>NYSE eri\u015fimi ve d\u00fc\u015f\u00fck komisyon \u00fccretleri sa\u011flay\u0131n<\/td><\/tr> <tr><td>2<\/td><td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Pratik i\u00e7in y\u00f6netilebilir bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>\"DGX\" sembol\u00fcn\u00fc aray\u0131n<\/td><td>Do\u011fru g\u00fcvenlik i\u00e7in tam sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>4<\/td><td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Limit emirleri volatilite s\u0131ras\u0131nda fazla \u00f6deme yapmay\u0131 \u00f6nler<\/td><\/tr> <tr><td>5<\/td><td>G\u00f6zden ge\u00e7irin ve onaylay\u0131n<\/td><td>\u0130\u015flem yapmadan \u00f6nce miktar ve toplam maliyeti iki kez kontrol edin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni DGX Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2> <p>Pocket Option, Quest Diagnostics ile ilgilenen yeni yat\u0131r\u0131mc\u0131lar i\u00e7in benzersiz avantajlar sunar:<\/p> <ul> <li><strong>Minimum 5 $ depozito<\/strong> stratejileri d\u00fc\u015f\u00fck riskle test etmeye olanak tan\u0131r<\/li> <li><strong>Tek belge ile h\u0131zl\u0131 do\u011frulama<\/strong> an\u0131nda ticaret eri\u015fimi sa\u011flar<\/li> <li><strong>Kripto para ve e-c\u00fczdanlar dahil<\/strong> \u00e7oklu para \u00e7ekme se\u00e7enekleri esneklik sunar<\/li> <li><strong>Pocket Option blogunda e\u011fitim kaynaklar\u0131<\/strong> sa\u011fl\u0131k sekt\u00f6r\u00fc dinamiklerini anlamaya yard\u0131mc\u0131 olur<\/li> <\/ul> <p>Uzun vadeli DGX pozisyonlar\u0131 i\u00e7in geleneksel arac\u0131 kurumlar tercih edilebilir, ancak Pocket Option'\u0131n d\u00fc\u015f\u00fck engelleri ilk pozisyon olu\u015fturma ve strateji testleri i\u00e7in idealdir.<\/p> <h2>\ud83c\udf0d 2025'te Quest Diagnostics: Sa\u011fl\u0131k Hizmetlerinin Tan\u0131sal Omurgas\u0131<\/h2> <p>Quest Diagnostics, klinik tan\u0131 pazar\u0131n\u0131n yakla\u015f\u0131k %20-26's\u0131n\u0131 domine ediyor, <strong>her \u00fc\u00e7 Amerikal\u0131 yeti\u015fkinden biri<\/strong> y\u0131ll\u0131k olarak hizmet al\u0131yor ve yakla\u015f\u0131k 50.000 \u00e7al\u0131\u015fan milyonlarca testi i\u015fliyor. Rutin kan testlerinin \u00f6tesinde, Grail ile ortakl\u0131\u011f\u0131 sayesinde ileri d\u00fczey kanser tespiti liderli\u011fini s\u00fcrd\u00fcr\u00fcyor ve d\u00fcnyan\u0131n en b\u00fcy\u00fck klinik laboratuvar sonu\u00e7lar\u0131 veritaban\u0131na sahip.<\/p> <p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek:<\/strong> Quest, yaln\u0131zca 2024 y\u0131l\u0131nda <strong>sekiz stratejik sat\u0131n alma<\/strong> ger\u00e7ekle\u015ftirdi; bunlar aras\u0131nda Kanada'daki LifeLabs da var\u2014bu da onlar\u0131 sa\u011fl\u0131k tan\u0131 alan\u0131nda en aktif konsolidat\u00f6rlerden biri yaparken uluslararas\u0131 ayak izlerini geni\u015fletiyor.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Quest Diagnostics Hissesi: G\u00fcncel Fiyat ve \u00d6nemli Tarihler<\/h2>\n<p>25 A\u011fustos 2025 itibar\u0131yla, Quest Diagnostics Incorporated (DGX) NYSE&#8217;de <strong>180,23 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>28 Ekim 2025<\/strong> kesinlikle kritik\u2014bu tarihte Quest 3. \u00e7eyrek kazan\u00e7 raporunu a\u00e7\u0131klayacak. Tarihsel olarak, bu \u00e7eyrek d\u00f6nem duyurular\u0131 \u00f6nemli fiyat hareketleri yarat\u0131yor.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 DGX Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<p>Son tarihe bak\u0131ld\u0131\u011f\u0131nda, Quest&#8217;in kazan\u00e7 g\u00fcnleri \u00f6zellikle volatil olmu\u015ftur:<\/p>\n<ul>\n<li><strong>22 Temmuz 2025<\/strong>: 2. \u00e7eyrek kazan\u00e7lar\u0131 beklentileri $2,62 EPS ile a\u015ft\u0131 (0,05 $ fazla) ve 2,76 milyar $ gelir (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NYSE\/DGX\/earnings\/\">MarketBeat<\/a>). Hisse senedi sonraki hafta %3,2 y\u00fckseldi<\/li>\n<li><strong>Nisan 2025<\/strong>: 1. \u00e7eyrek sonu\u00e7lar\u0131 %12 gelir art\u0131\u015f\u0131 g\u00f6sterdi, \u00fc\u00e7 i\u015flem g\u00fcn\u00fcnde %5,1 art\u0131\u015f tetikledi<\/li>\n<li><strong>Ocak 2025<\/strong>: Y\u0131ll\u0131k rehberlik art\u0131\u015f\u0131 \u015eubat boyunca %7,8&#8217;lik s\u00fcrekli bir ralliyi tetikledi<\/li>\n<\/ul>\n<p>Desen a\u00e7\u0131k: pozitif s\u00fcrprizler an\u0131nda momentum yarat\u0131rken, k\u00fc\u00e7\u00fck ka\u00e7\u0131rmalar bile ge\u00e7ici d\u00fc\u015f\u00fc\u015flere neden olabilir; ancak Quest&#8217;in savunmac\u0131 i\u015f modeli sayesinde bu d\u00fc\u015f\u00fc\u015fler genellikle haftalar i\u00e7inde toparlan\u0131r.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu: Son Konsolidasyonla \u0130stikrarl\u0131 T\u0131rman\u0131\u015f<\/h2>\n<p>Quest Diagnostics, piyasa dalgalanmalar\u0131 aras\u0131nda ola\u011fan\u00fcst\u00fc bir istikrar g\u00f6sterdi:<\/p>\n<p><strong>\u015eubat 2025<\/strong>: 162,50 $ (tatil sonras\u0131 sa\u011fl\u0131k sekt\u00f6r\u00fc rotasyonu)<br \/> <strong>Mart 2025<\/strong>: 171,80 $ (LifeLabs Kanada anla\u015fmas\u0131 haberleriyle hareketlilik)<br \/> <strong>May\u0131s 2025<\/strong>: 178,40 $ (g\u00fc\u00e7l\u00fc 1. \u00e7eyrek kazan\u00e7 momentumu)<br \/> <strong>Temmuz 2025<\/strong>: 183,50 $ (2. \u00e7eyrek kazan\u00e7lar\u0131 ve rehberlik art\u0131\u015f\u0131)<br \/> <strong>A\u011fustos 2025<\/strong>: 180,23 $ (52 haftal\u0131k zirvelere yak\u0131n mevcut konsolidasyon)<\/p>\n<p>Hisse senedi bu alt\u0131 ayl\u0131k d\u00f6nemde yakla\u015f\u0131k <strong>%11,2<\/strong> de\u011fer kazand\u0131, bir\u00e7ok sa\u011fl\u0131k sekt\u00f6r\u00fc rakibini geride b\u0131rak\u0131rken karakteristik d\u00fc\u015f\u00fck volatilitesini (beta 0,46) korudu. Bu istikrarl\u0131 de\u011fer art\u0131\u015f\u0131, hem operasyonel m\u00fckemmeliyeti hem de ekonomik belirsizlik d\u00f6nemlerinde tan\u0131sal hizmetlerin savunmac\u0131 do\u011fas\u0131n\u0131 yans\u0131t\u0131yor.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p>Kapsaml\u0131 analist projeksiyonlar\u0131 ve sekt\u00f6r trendlerine dayanarak:<\/p>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 188-195 $ (3. ve 4. \u00e7eyrek kazan\u00e7lar\u0131 sonras\u0131 \u0131l\u0131ml\u0131 b\u00fcy\u00fcme) \u2192 <strong>AL<\/strong><br \/> <strong>2026 Hedefi<\/strong>: 204-215 $ (geni\u015fleyen tan\u0131sal hizmetlerden %8-12 b\u00fcy\u00fcme)<br \/> <strong>2028 Projeksiyonu<\/strong>: 230-245 $ (Yapay zeka entegrasyonundan bile\u015fik y\u0131ll\u0131k b\u00fcy\u00fcme)<br \/> <strong>2030 Vizyonu<\/strong>: 260-280 $ (ya\u015flanan n\u00fcfus talebi ve ki\u015fiselle\u015ftirilmi\u015f t\u0131p benimsemesi)<\/p>\n<p>Ortak g\u00f6r\u00fc\u015f, Quest&#8217;in pazar liderli\u011fi, tekrarlayan gelir modeli ve artan tan\u0131sal test ihtiyac\u0131 nedeniyle iyimserdir.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler:<\/h3>\n<ul>\n<li><strong>Artan bor\u00e7 y\u00fck\u00fc<\/strong> D\/E oran\u0131 0,71 ile finansal esnekli\u011fi k\u0131s\u0131tlayabilir<\/li>\n<li><strong>Sa\u011fl\u0131k geri \u00f6demelerinde d\u00fczenleyici de\u011fi\u015fiklikler<\/strong> marjlar \u00fczerinde bask\u0131 olu\u015fturabilir<\/li>\n<li><strong>Teknik g\u00f6stergeler<\/strong> son zay\u0131fl\u0131kla 4,87\/10 puan g\u00f6steriyor<\/li>\n<li><strong>Makroekonomik duyarl\u0131l\u0131k<\/strong> t\u00fcketici sa\u011fl\u0131k harcamalar\u0131 d\u00fc\u015ferse etkilenebilir<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar:<\/h3>\n<ul>\n<li><strong>2. \u00e7eyrek kazan\u00e7lar\u0131 a\u015fmas\u0131<\/strong> %15,2 gelir art\u0131\u015f\u0131 ve tam y\u0131l rehberli\u011fi y\u00fckseltti<\/li>\n<li><strong>Kurumsal hesap geni\u015flemesi<\/strong> tutarl\u0131 gelir ak\u0131\u015flar\u0131n\u0131 destekliyor<\/li>\n<li><strong>Otomasyon kazan\u0131mlar\u0131<\/strong> operasyonel verimlilik ve karl\u0131l\u0131\u011f\u0131 art\u0131r\u0131yor<\/li>\n<li><strong>\u00c7eyreklik temett\u00fc art\u0131\u015f\u0131<\/strong> 0,80 $ (y\u00fczde 6,7 art\u0131\u015f) g\u00fcven sinyali<\/li>\n<li><strong>Ekonomik belirsizlikte sa\u011fl\u0131k sekt\u00f6r\u00fc istikrar\u0131<\/strong><\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>Dolar-maliyet ortalamas\u0131<\/strong> &#8211; Zamanlama hatalar\u0131n\u0131 \u00f6nlemek i\u00e7in ayl\u0131k sabit tutarlarda yat\u0131r\u0131m yap\u0131n<\/li>\n<li><strong>Kazan\u00e7 uyar\u0131lar\u0131 ayarlay\u0131n<\/strong> &#8211; Potansiyel giri\u015f f\u0131rsatlar\u0131 i\u00e7in 28 Ekim&#8217;i takip edin<\/li>\n<li><strong>Ak\u0131ll\u0131ca tahsis yap\u0131n<\/strong> &#8211; DGX&#8217;i portf\u00f6y\u00fcn\u00fcz\u00fcn %5-10&#8217;u aras\u0131nda tutarak sekt\u00f6r \u00e7e\u015fitlendirmesi sa\u011flay\u0131n<\/li>\n<li><strong>Temett\u00fcleri yeniden yat\u0131r\u0131n<\/strong> &#8211; %1,78 getiri bile\u015fik b\u00fcy\u00fcme i\u00e7in kullan\u0131n<\/li>\n<\/ol>\n<p>Esprili bir bak\u0131\u015f: &#8220;DGX ticareti, laboratuvar sonu\u00e7lar\u0131n\u0131 almak gibidir &#8211; bazen iyi haberi almak i\u00e7in i\u015flem s\u00fcresini beklemeniz gerekir. Sab\u0131r genellikle \u00f6d\u00fcllendirilir!&#8221;<\/p>\n<h2>\u2705 Quest Diagnostics Incorporated (DGX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Yat\u0131r\u0131m platformu se\u00e7in<\/td>\n<td>NYSE eri\u015fimi ve d\u00fc\u015f\u00fck komisyon \u00fccretleri sa\u011flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap fonlamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Pratik i\u00e7in y\u00f6netilebilir bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>&#8220;DGX&#8221; sembol\u00fcn\u00fc aray\u0131n<\/td>\n<td>Do\u011fru g\u00fcvenlik i\u00e7in tam sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Emir t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Limit emirleri volatilite s\u0131ras\u0131nda fazla \u00f6deme yapmay\u0131 \u00f6nler<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>G\u00f6zden ge\u00e7irin ve onaylay\u0131n<\/td>\n<td>\u0130\u015flem yapmadan \u00f6nce miktar ve toplam maliyeti iki kez kontrol edin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni DGX Yat\u0131r\u0131mc\u0131lar\u0131 \u0130\u00e7in Uygun?<\/h2>\n<p>Pocket Option, Quest Diagnostics ile ilgilenen yeni yat\u0131r\u0131mc\u0131lar i\u00e7in benzersiz avantajlar sunar:<\/p>\n<ul>\n<li><strong>Minimum 5 $ depozito<\/strong> stratejileri d\u00fc\u015f\u00fck riskle test etmeye olanak tan\u0131r<\/li>\n<li><strong>Tek belge ile h\u0131zl\u0131 do\u011frulama<\/strong> an\u0131nda ticaret eri\u015fimi sa\u011flar<\/li>\n<li><strong>Kripto para ve e-c\u00fczdanlar dahil<\/strong> \u00e7oklu para \u00e7ekme se\u00e7enekleri esneklik sunar<\/li>\n<li><strong>Pocket Option blogunda e\u011fitim kaynaklar\u0131<\/strong> sa\u011fl\u0131k sekt\u00f6r\u00fc dinamiklerini anlamaya yard\u0131mc\u0131 olur<\/li>\n<\/ul>\n<p>Uzun vadeli DGX pozisyonlar\u0131 i\u00e7in geleneksel arac\u0131 kurumlar tercih edilebilir, ancak Pocket Option&#8217;\u0131n d\u00fc\u015f\u00fck engelleri ilk pozisyon olu\u015fturma ve strateji testleri i\u00e7in idealdir.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Quest Diagnostics: Sa\u011fl\u0131k Hizmetlerinin Tan\u0131sal Omurgas\u0131<\/h2>\n<p>Quest Diagnostics, klinik tan\u0131 pazar\u0131n\u0131n yakla\u015f\u0131k %20-26&#8217;s\u0131n\u0131 domine ediyor, <strong>her \u00fc\u00e7 Amerikal\u0131 yeti\u015fkinden biri<\/strong> y\u0131ll\u0131k olarak hizmet al\u0131yor ve yakla\u015f\u0131k 50.000 \u00e7al\u0131\u015fan milyonlarca testi i\u015fliyor. Rutin kan testlerinin \u00f6tesinde, Grail ile ortakl\u0131\u011f\u0131 sayesinde ileri d\u00fczey kanser tespiti liderli\u011fini s\u00fcrd\u00fcr\u00fcyor ve d\u00fcnyan\u0131n en b\u00fcy\u00fck klinik laboratuvar sonu\u00e7lar\u0131 veritaban\u0131na sahip.<\/p>\n<p><strong>2025 \u0130lgin\u00e7 Ger\u00e7ek:<\/strong> Quest, yaln\u0131zca 2024 y\u0131l\u0131nda <strong>sekiz stratejik sat\u0131n alma<\/strong> ger\u00e7ekle\u015ftirdi; bunlar aras\u0131nda Kanada&#8217;daki LifeLabs da var\u2014bu da onlar\u0131 sa\u011fl\u0131k tan\u0131 alan\u0131nda en aktif konsolidat\u00f6rlerden biri yaparken uluslararas\u0131 ayak izlerini geni\u015fletiyor.<\/p>\n"},"faq":[{"question":"Quest Diagnostics hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir yat\u0131r\u0131m platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"DGX\" sembol\u00fcn\u00fc aray\u0131n, emir t\u00fcr\u00fcn\u00fc se\u00e7in ve i\u015flemi onaylayarak sat\u0131n alma i\u015flemini tamamlay\u0131n."},{"question":"Quest Diagnostics hisseleri i\u00e7in 2025-2030 fiyat tahmini nedir?","answer":"2025 sonunda 188-195 $ aral\u0131\u011f\u0131nda, 2030 y\u0131l\u0131nda ise 260-280 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"Quest Diagnostics'in temel riskleri nelerdir?","answer":"Artan bor\u00e7 y\u00fck\u00fc, sa\u011fl\u0131k geri \u00f6demelerinde d\u00fczenleyici de\u011fi\u015fiklikler, teknik g\u00f6stergelerde zay\u0131fl\u0131k ve makroekonomik duyarl\u0131l\u0131k ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar Quest Diagnostics hisseleri i\u00e7in ne yapmal\u0131?","answer":"Dolar-maliyet ortalamas\u0131 yapmal\u0131, kazan\u00e7 uyar\u0131lar\u0131 ayarlamal\u0131, portf\u00f6yde %5-10 oran\u0131nda DGX bulundurmal\u0131 ve temett\u00fcleri yeniden yat\u0131rmal\u0131d\u0131r."},{"question":"Pocket Option yeni DGX yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7oklu para \u00e7ekme se\u00e7enekleri ve e\u011fitim kaynaklar\u0131 sunmas\u0131 nedeniyle yeni yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Quest Diagnostics hisseleri nas\u0131l sat\u0131n al\u0131n\u0131r?","answer":"Bir yat\u0131r\u0131m platformu se\u00e7in, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"DGX\" sembol\u00fcn\u00fc aray\u0131n, emir t\u00fcr\u00fcn\u00fc se\u00e7in ve i\u015flemi onaylayarak sat\u0131n alma i\u015flemini tamamlay\u0131n."},{"question":"Quest Diagnostics hisseleri i\u00e7in 2025-2030 fiyat tahmini nedir?","answer":"2025 sonunda 188-195 $ aral\u0131\u011f\u0131nda, 2030 y\u0131l\u0131nda ise 260-280 $ aral\u0131\u011f\u0131nda fiyatlar beklenmektedir."},{"question":"Quest Diagnostics'in temel riskleri nelerdir?","answer":"Artan bor\u00e7 y\u00fck\u00fc, sa\u011fl\u0131k geri \u00f6demelerinde d\u00fczenleyici de\u011fi\u015fiklikler, teknik g\u00f6stergelerde zay\u0131fl\u0131k ve makroekonomik duyarl\u0131l\u0131k ba\u015fl\u0131ca risklerdir."},{"question":"Yeni ba\u015flayanlar Quest Diagnostics hisseleri i\u00e7in ne yapmal\u0131?","answer":"Dolar-maliyet ortalamas\u0131 yapmal\u0131, kazan\u00e7 uyar\u0131lar\u0131 ayarlamal\u0131, portf\u00f6yde %5-10 oran\u0131nda DGX bulundurmal\u0131 ve temett\u00fcleri yeniden yat\u0131rmal\u0131d\u0131r."},{"question":"Pocket Option yeni DGX yat\u0131r\u0131mc\u0131lar\u0131 i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7oklu para \u00e7ekme se\u00e7enekleri ve e\u011fitim kaynaklar\u0131 sunmas\u0131 nedeniyle yeni yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Quest Diagnostics Incorporated (DGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Quest Diagnostics Incorporated (DGX) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Quest Diagnostics Incorporated (DGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Quest Diagnostics Incorporated (DGX) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T09:36:11+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Quest Diagnostics Incorporated (DGX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Quest Diagnostics Incorporated (DGX) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-25T09:36:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/\",\"name\":\"Quest Diagnostics Incorporated (DGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Quest Diagnostics Incorporated (DGX) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"datePublished\":\"2025-08-25T09:36:11+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Quest Diagnostics Incorporated (DGX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Quest Diagnostics Incorporated (DGX) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Quest Diagnostics Incorporated (DGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Quest Diagnostics Incorporated (DGX) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/","og_locale":"tr_TR","og_type":"article","og_title":"Quest Diagnostics Incorporated (DGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Quest Diagnostics Incorporated (DGX) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T09:36:11+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Quest Diagnostics Incorporated (DGX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Quest Diagnostics Incorporated (DGX) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-25T09:36:11+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/","name":"Quest Diagnostics Incorporated (DGX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Quest Diagnostics Incorporated (DGX) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","datePublished":"2025-08-25T09:36:11+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals8.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Quest Diagnostics Incorporated (DGX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Quest Diagnostics Incorporated (DGX) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":346014,"slug":"how-to-buy-quest-diagnostics-incorporated","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Quest Diagnostics Incorporated (DGX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Quest Diagnostics Incorporated (DGX)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/"},"pt_AA":{"locale":"pt_AA","id":346016,"slug":"how-to-buy-quest-diagnostics-incorporated","post_title":"Como comprar a\u00e7\u00f5es da Quest Diagnostics Incorporated (DGX) - Investimento em a\u00e7\u00f5es da Quest Diagnostics Incorporated (DGX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-quest-diagnostics-incorporated\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/346021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=346021"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/346021\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334054"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=346021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=346021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=346021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}